Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Cognitive dysfunctions in schizophrenia - Medical and psychological treatment
Autore:
Sachs, G; Katschnig, H;
Indirizzi:
Univ Vienna, Psychiat Klin, Klin Abt Sozialpsychiat & Evaluationsforsch, A-1090 Vienna, Austria Univ Vienna Vienna Austria A-1090 luationsforsch, A-1090 Vienna, Austria
Titolo Testata:
PSYCHIATRISCHE PRAXIS
fascicolo: 2, volume: 28, anno: 2001,
pagine: 60 - 68
SICI:
0303-4259(200103)28:2<60:CDIS-M>2.0.ZU;2-X
Fonte:
ISI
Lingua:
GER
Soggetto:
CARD SORTING TEST; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; PSYCHIATRIC-SYMPTOMS; PSYCHOTIC-PATIENTS; NEGATIVE SYMPTOMS; WORKING-MEMORY; FIRST-EPISODE; DEFICITS; REMEDIATION; ATTENTION;
Tipo documento:
Review
Natura:
Periodico
Settore Disciplinare:
Social & Behavioral Sciences
Citazioni:
107
Recensione:
Indirizzi per estratti:
Indirizzo: Sachs, G Univ Vienna, Psychiat Klin, Klin Abt Sozialpsychiat & Evaluationsforsch, Wahringer Gurtel 18-20, A-1090 Vienna, Austria Univ Vienna Wahringer Gurtel 18-20 Vienna Austria A-1090 Austria
Citazione:
G. Sachs e H. Katschnig, "Cognitive dysfunctions in schizophrenia - Medical and psychological treatment", PSYCHIAT PR, 28(2), 2001, pp. 60-68

Abstract

Primarily from the perspective of psychopharmacology, schizophrenic symptomatology has recently been dichotomized into "plus" and "minus" symptoms, although the role of cognitive dysfunctions has been regarded as particularly important for the diagnosis since the time of Eugen Bleuler. Many studiesshow that schizophrenic patients suffer consistently from cognitive dysfunction. Among these, are impairments of attention and memory functions as well as executive functions such as planning and problem solving. These impairments are stable or progressive and often continue into the remission phase of schizophrenia and impair both social integration as well as occupational performance. In this overview, research results on cognitive dysfunctionin patients with schizophrenic illnesses and their relation to psychosocial disabilities are described first. The therapeutic value and possible clinical-practice implications of atypical anti-psychotics and various cognitive therapy methods are then presented. Methodological weaknesses and open questions, both pharmacological and with regard to cognitive interventions, are discussed.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/01/20 alle ore 10:08:43